Cite
HARVARD Citation
Sato, S. et al. (2021). The new prognostic score for unresectable or recurrent gastric cancer treated with nivolumab: A multi‐institutional cohort study. Annals of gastroenterological surgery. 5 (6), pp. 794-803. [Online].